Inventor
Anna-Maria A. Hays Putnam
Inventor
San Diego, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes24%
C12NMicroorganisms or enzymes12%
Y02ATechnologies for adaptation to climate change7%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
C07HSugars1%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
C40BCombinatorial chemistry1%
PatentTitleYear
10,377,805Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses201910,138,283Modified bovine G-CSF polypeptides and their uses20189,975,936Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids20189,938,333Modified leptin polypeptides and their uses20189,644,014'Modified animal erythropoietin polypeptides and their uses'20179,517,273'Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids'20169,488,660'Methods and compositions comprising non-natural amino acids'20169,156,899'Modified animal erythropoietin polypeptides and their uses'20159,079,971'Modified FGF-21 polypeptides comprising non-naturally occurring amino acids'20159,074,010'Modified human plasma polypeptide or Fc scaffolds and their uses'20158,946,148'Modified insulin polypeptides and their uses'20158,618,257'Modified human plasma polypeptide or Fc scaffolds and their uses'20138,569,233'Modified animal erythropoietin polypeptides and their uses'20138,383,365'Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives'20138,329,869'Modified interferon beta polypeptides and their uses'20128,278,418'Modified animal erythropoietin polypeptides and their uses'20128,232,371'Modified human interferon polypeptides and their uses'20128,114,630'Modified interferon beta polypeptides and their uses'20128,053,560'Modified human plasma polypeptide or Fc scaffolds and their uses'20118,022,186'Modified human plasma polypeptide or Fc scaffolds and their uses'20118,012,931'Modified FGF-21 polypeptides and their uses'20117,919,591'Modified human plasma polypeptide or Fc scaffolds and their uses'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2019Patents assigned to AMBRX INC (22)· patent assignee history
2011–2019Based in San Diego, CA, US· patent location history
2012–2016Patents assigned to HAYS PUTNAM ANNA-MARIA A (10)· patent assignee history
2012–2018Patents assigned to KNUDSEN NICK (6)· patent assignee history
2012–2018Patents assigned to KRAYNOV VADIM (6)· patent assignee history
2012–2016Patents assigned to TIAN FENG (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMBRX INC | 22 | 2011–2019 |
| HAYS PUTNAM ANNA-MARIA Aself | 10 | 2012–2016 |
| KNUDSEN NICK | 6 | 2012–2018 |
| KRAYNOV VADIM | 6 | 2012–2018 |
| TIAN FENG | 6 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 22 | 2011–2019 |